Increased Nuchal Translucency, Hydrops fetalis or Hygroma colli
Autor: | Karsten R. Held, J. Jenderny, B.J. Hackelöer, S. Kerber, Kurt Hecher, W. Schmidt, L. Kochhan |
---|---|
Rok vydání: | 2001 |
Předmět: |
Embryology
medicine.medical_specialty medicine.diagnostic_test business.industry Obstetrics Obstetrics and Gynecology Chorionic villus sampling Prenatal diagnosis General Medicine medicine.disease Nuchal translucency Hydrops fetalis Nuchal Translucency Measurement Pediatrics Perinatology and Child Health medicine Gestation Radiology Nuclear Medicine and imaging business Hygroma colli Increased nuchal translucency |
Zdroj: | Fetal Diagnosis and Therapy. 16:211-214 |
ISSN: | 1421-9964 1015-3837 |
DOI: | 10.1159/000053912 |
Popis: | Objectives: Nuchal translucency measurement of 3 mm or more (≧95th centile for gestation age), hydrops fetalis or hygroma colli between the 11th and 14th weeks of gestation is associated with a higher risk of fetal Down syndrome and other aneuploidies. So far, chromosome preparation of chorionic villi samplings (CVS) after short-term (or direct) culture is the only valid, reliable and rapid method of choice for the early detection of chromosomal aberrations. However, because of the placental mosaicisms detected after short-term culture, CVS has to be confirmed by a second method. Moreover, short-term villi preparation does not always provide a sufficient quantity and quality of metaphases to enable cytogenetic analysis. Unfortunately, a predicative cytogenetic result will be available only after long-term cultivation (usually after 1–2 weeks). An alternative rapid method, inexpensive and suitable for diagnosing autosomal trisomies, is the quantitative fluorescence polymerase reaction (QF-PCR) using different polymorphic small tandem repeats (STRs) on CVS-DNA. Therefore, it was the aim of the study to evaluate whether a new CVS test strategy could be employed in early pregnancies at high risk after the rapid detection of fetal chromosomal abnormalities by QF-PCR for chromosomes 13, 18 or 21 and sexing in conjunction with short-term chromosome analysis. Materials: Nineteen CVS were chosen for QF-PCR detection of trisomy 21, 18 or 13 after an increased nuchal translucency measurement (≧95th centile for gestation age), a hydrops fetalis or a hygroma colli. The amelogenin locus of chromosomes X and Y (AMXY) were used for sexing. The QF-PCR results were compared with routine karyotyping after short- and/or long-term cultivation of CVS cells. Results: An informative result was demonstrated in all analysed specimens. Nine CVS were diagnosed as a QF-PCR trisomy either for chromosome 21, 18 and 13. The pathological samples also included 4 cases of mosaicism where the normal cell line was not identified by QF-PCR. In 1 additional case with a normal QF-PCR result, short-term CVS chromosome analysis showed a mosaic trisomy 13, whereas longterm CVS culture revealed a normal karyotype. The malformed aborted fetus showed no clinical signs of trisomy 13, confirming the normal results obtained by QF-PCR and long-term CVS chromosome analysis. One pregnancy with a Turner syndrome was not identified by molecular analysis. Conclusions: This study showed that all early pregnancies with a clinically relevant autosomal trisomy could be detected prenatally in routine practice by QF-PCR. The combined use of both rapid methods – QF-PCR and short-term chromosome analysis – optimise the results by minimising the possibility of false-positive or false-negative findings. We believe that after verification of a pathological result obtained by two independent methods (QF-PCR and short-term CVS chromosome analysis), long-term villi cultivation is no longer necessary. However, in all cases with discrepancies, especially in samples with mosaic findings at short-term CVS cultivation, further studies are still necessary. |
Databáze: | OpenAIRE |
Externí odkaz: |